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Abstract
The relationships among hippocampal neurogenesis, depression and the mechanism of action of antidepressant drugs have
generated a considerable amount of controversy. The cyclin-dependent kinase (Cdk) inhibitor p21
Cip1 (p21) plays a crucial
role in restraining cellular proliferation and maintaining cellular quiescence. Using in vivo and in vitro approaches the
present study shows that p21 is expressed in the subgranular zone of the dentate gyrus of the hippocampus in early
neuronal progenitors and in immature neurons, but not in mature neurons or astroglia. In vitro, proliferation is higher in
neuronal progenitor cells derived from p21-/- mice compared to cells derived from wild-type mice. Proliferation is increased
in neuronal progenitor cells after suppression of p21 using lentivirus expressing short hairpin RNA against p21. In vivo,
chronic treatment with the non-selective antidepressant imipramine as well as the norepinephrine-selective reuptake
inhibitor desipramine or the serotonin-selective reuptake inhibitor fluoxetine all decrease p21 expression, and this was
associated with increased neurogenesis. Chronic antidepressant treatment did not affect the expression of other Cdk
inhibitors. Untreated p21-/- mice exhibit a higher degree of baseline neurogenesis and decreased immobility in the forced
swim test. Although chronic imipramine treatment increased neurogenesis and reduced immobility in the forced swim test
in wild-type mice, it reduced neurogenesis and increased immobility in p21-/- mice. These results demonstrate the unique
role of p21 in the control of neurogenesis, and support the hypothesis that different classes of reuptake inhibitor-type
antidepressant drugs all stimulate hippocampal neurogenesis by inhibiting p21 expression.
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Introduction
The subgranular zone (SGZ) of the dentate gyrus of the
hippocampus and the subventricular zone, which lines the border
between the striatum and the lateral ventricle, are known to
produce new neurons throughout life. Neuronal stem cells express
glial fibrillary acidic protein (GFAP) [1]. Unlike in the subven-
tricular zone, in the hippocampus most of the cells isolated by stem
cell neurosphere assays express SOX2 and nestin, both markers of
quiescent neuronal stem cells and amplifying neuronal progenitors
[2]; however, very few cells express GFAP. Therefore, hippocam-
pal neural stem cells are referred as ‘‘neuronal progenitor cells’’
(NPC) [2,3].
The relationships among hippocampal neurogenesis, depression
and the mechanism of action of antidepressants have generated a
considerable amount of interest and controversy. Most antide-
pressant drugs produce a rapid increase in synaptic levels of
norepinephrine and/or serotonin; however, the onset of clinical
improvement usually takes 3–4 weeks [4]. Thus, the initial
increase in levels of these biogenic amines must trigger
downstream events that after some time lead to a therapeutic
effect. It has been suggested that stimulation of hippocampal
neurogenesis is one of these downstream events. Maturation of
newly developed neurons also requires about 3–4 weeks, and
different classes of antidepressants stimulate the proliferation of
neuronal progenitors [5,6,7] and increase the survival of newly
developed neurons [8]. In addition, ablation of neurogenesis by
irradiation reduces some of the effects antidepressants [9,10,11].
Thus, intact hippocampal neurogenesis is required for at least
some of the behavioral effects of antidepressants in animal models.
These findings point to a potential mechanistic link between
neurogenesis and the mechanism of action of antidepressant drugs.
The end-point molecular mechanisms regulating hippocampal
neurogenesis are not clear. In mammalian cells, the control of
proliferation primarily occurs in the G1 phase of the cell cycle
[12]. Cyclin/Cdk complexes are negatively regulated by two
families of Cdk inhibitors: the Ink4/Arf family (p15, p16, p18 and
p19); and the Cip/Kip family (p21, p27 and p57) [13]. By
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from the G1 to the S phase. The Cdk inhibitor p21
Cip1 (p21) plays
a crucial role in restraining proliferation and maintaining cellular
quiescence [14].
Previously, we showed that p21 is expressed in the SGZ of the
hippocampus [15]. In the present study we examined in details the
specific cell types that express p21, and the functional significance
of its expression in the SGZ are defined. We analyzed the effects of
different classes of antidepressants on SGZ p21 expression and
examined neurogenesis in p21-/- mice at baseline and after
chronic imipramine treatment. Behavior of wild-type (WT) and
p21-/- mice after chronic imipramine treatment was compared
and contrasted using the forced swim test. The results show that
p21 is expressed in transit-amplifying progenitors and neuroblasts
and negatively regulates proliferation of these cells. Chronic
treatment with different classes of antidepressant drugs all inhibit
the expression of p21, but do not affect the expression of other
Cdk inhibitors, and this is associated with increased neurogenesis.
These results suggest that p21 uniquely regulates NPC prolifer-
ation, and by inhibiting p21, reuptake inhibitor-type antidepres-
sants release proliferation restraint and increase neurogenesis in
the hippocampus.
Methods
Experimental animals
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee at Cedars-Sinai Medical Center (project# 2263).
C57Bl/6 and p21-/- (Cdk1a
tm1Tyj) mice were originally purchased
from the Jackson Laboratory, but currently are bred in our
laboratory. p21-/- mice were backcrossed to the C57Bl/6 genetic
background 6 times prior to testing. p21+/- females and males
were used for breeding, and both WT and p21-/- animals were
obtained from the same litters. Two month old male mice were
used for the experiments. For Western blot analyses and for
obtaining NPC, the mice were sacrificed by cervical dislocation,
the brains removed and rapidly cooled in ice-cold saline and the
hippocampi were dissected out [16]. For the immunohistochem-
istry studies the mice were anesthetized with isoflurane and
perfused with paraformaldehyde (4%). Separate groups of mice
were used for the behavioral studies.
Drugs
The doses were based upon those that produce behavioral
changes (reduce immobility in the forced swim test), increase
neurogenesis and/or produce neurochemical changes reflective of
antidepressant action [17,18,19]. Fluoxetine hydrochloride (Spec-
trum Chemicals) (10 mg/kg/day) initially was dissolved in distilled
water and diluted in normal saline to volume prior to injection.
Imipramine hydrochloride (Sigma-Aldrich) (10 mg/kg/day) and
desipramine hydrochloride (Sigma-Aldrich) (20 mg/kg/day) were
dissolved in normal saline. The doses are expressed as the salt
form. Drugs were injected i.p. in a volume of 1 ml/100 g body
weight once a day for 3 weeks.
Bromodeoxyuridine (BrdU) incorporation
BrdU incorporation was assessed as described previously [15].
The mice were injected every two hr with BrdU (Sigma-Aldridge,
100 mg/kg/i.p) for a total of three injections and then sacrificed
24 hr after the first BrdU injection. The entire left half of the
brain was cut into sagittal sections (5 mm) and processed using a
BrdU Labeling and Detection Kit (Roche Applied Biosystems).
Sections were coded for blind data analysis. Cutting of sections
from 0.36 to 0.6 mm lateral to the midline was carried out (55).
Every third section (total 30 sections) was counted under a x100
objective and the sum was multiplied by 3 to estimate the total
number of BrdU-positive cells in the region. Cells were counted if
they were in or touching the SGZ and excluded if they were more
than two cell diameters from the GCL [7]. Some sections were
double-labeled to detect DCX, and BrdU-positive cells were
examined by confocal microscopy to determine co-localization
with DCX.
Protein isolation and Western blot analysis
Analyses were conducted as described previously [20]. The
following antibodies were used: p21, p18, p27 b-actin (Santa Cruz
Biotechnology) and cleaved caspase 3 (Abcam). DCX and NeuN
antibodies were the same as used for the immunohistochemistry
studies (see below).
Adult NPC cultures
Cultures were prepared and conducted according to published
protocols [1,2,21]. Two month old WT and p21-/- mice were
sacrificed, the hippocampi dissected and dissociated using Papain
Dissociation System (Worthington Biochemicals). The NPC cells
were isolated and cultured using Neural Stem Cell Expansion Kit
Neurosphere System in serum-free neurobasal A-medium (R&D
Systems). The single-cell suspension was re-suspended in
DMEMF-12 medium supplemented with N-2 Plus Media
Supplement, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/
ml streptomycin, 10 ng/ml FGF-2 and 20 ng/ml EGF. Under
these conditions only stem/neuronal progenitors survive and form
spheres. Cells were dispersed and passaged weekly and passages 2 -
4 were used for the experiments. Differentiation was induced by
growing in Complete NeuroCult NSC Differentiation Medium
(StemCell Technologies) in the absence of FGF-2 and EGF, and
5610
4 cells/ml were plated on ECL cell Attachment Matrix
coated coverslips (Upstate, 5–10 mg/cm
2) in 24 well plates and
cultured for 3 days (to detect DCX-positive cells) or for 8 days.
Cells were then fixed in 4% paraformaldehyde and immunocy-
tochemistry performed to detect neuronal markers.
Sphere self-renewal analysis
NPC cells were isolated from 2 month old WT and p21-/- mice.
After the culture was established, at passage 2 the spheres were
collected, dispersed and 0.5 cells/well were seeded in 96 well
plates in quadruplicate. Ten days later the number of spheres/well
was counted as a percentage of cells capable of forming spheres.
All spheres were then collected, dispersed and the total number of
cells derived from the spheres was counted in each culture.
Transient transfection of NPC with short hairpin RNA
(shRNA) against p21
Lentiviral-based particles permit efficient infection and integra-
tion of specific shRNA constructs into non-dividing cells such as
neuronal precursors. MissionHLentiviral Transduction Particles
(Sigma-Aldrich) consist of sequence-verified p21 shRNA cloned
into pLKO.1-puro lentiviral vectors. The viral titer was greater
than 1.5610
7 transducing units. At passage 2 or 3 the spheres were
collected, dispersed and plated at 5000 cell/well in 24-well plates
in duplicate. Transducing lentiviral particles expressing p21
shRNA or control non-targeting shRNA were added in the
amount calculated to reach optimal multiplicity of infection (MOI)
of 20 units. After 48 hr the cells were re-infected with the same
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dehyde 48 hr after the second infection.
Immunohisto- and cytochemistry studies
Brain paraffin sections (5 mM) or coverslips were double-labeled
with primary antibodies conjugated with Alexa 488 and Alexa 568
fluorescent dyes (Molecular Probe)[20]. The following antibodies
were used: p21 (BD Pharmingen), NeuN (Chemicon), SOX2 and
GFAP (both Millipore), BrdU (Santa Cruz Biotechnology), DCX,
nestin, Ki67 (all Abcam) and Tuj-1 (Stem Cell Technology). DNA
(nuclei) was stained with DAPI (Prolong Gold, Invitrogen). Three
independently performed stains were analyzed for each antibody.
Immunoreactive cells were determined in 3–10 random fields
(total number of cells between 500 and 5,000 depending on
experiment). Multiparameter fluorescent microscopy and Leica
Confocal Software was used to identify localization and co-
localization of these proteins.
Forced Swim Test (FST)
The FST is used primarily as a screen for detecting
antidepressant activity, but it also has been used to study animal
models of depression [22]. Immobility (defined as the absence of
active, escape-oriented behaviors such as swimming, jumping,
rearing, sniffing or diving) has been associated with depression-like
behavior (i.e., behavioral despair or learned helplessness). The
forced swim test was performed as described previously [23,24].
The level of illumination in the rooms during experimental testing
was 325 lux. The mice were individually placed into a Plexiglas
cylinder (25 cm height, 10 cm diameter) containing 16 cm of
water maintained at 22–24uC. The duration of the test was 6 min,
and the behavioral responses were videotaped. At a later date the
videotapes were viewed, and trained raters recorded the total
duration of time spent immobile (defined as the absence of active,
escape-oriented behaviors such as swimming, jumping, rearing,
sniffing or diving). The raters were blind to the experimental
treatment.
Statistical analysis
Independent-samples t-tests were used to analyze paired and
planned comparisons. Groups with more than 2 comparisons were
analyzed using one-way ANOVA (to determine the effects of
treatments) followed by the Dunnett’s test for pairwise compar-
isons to controls, or two-way ANOVA (to determine the effects of
genotype and treatments) followed by the Newman-Keuls posthoc
test for all pairwise comparisons. In one instance where
homogeneity of variance was not met, the non-parametric
Kruskal-Wallis test was used followed by a multiple comparisons
of means to detect differences between groups. The level of
significance for all analyses was set at p,0.05.
Results
p21 is expressed in hippocampal neuronal progenitor
cells in vivo
In the hippocampus, NPC constitute slow dividing quiescent
radial ‘‘stem’’ cells (GFAP
+/SOX2
+ or GFAP
+/nestin
+ type 1
cells), transit amplifying progenitors (GFAP
2/SOX2
+ and
GFAP
2/nestin
+ type 2a cells, or GFAP
2/nestin
+/DCX
+ type
2b cells), and neuroblasts (DCX
+/bIII-tubulin
+), but not mature
neurons (NeuN
+; type 3 cells) [2,25]. Previously, it was shown that
in the hippocampus, p21 is expressed exclusively in the SGZ, in
the neurogenic niche [15]. Using specific neuronal markers,
immunofluorescent confocal analysis confirmed this previous
observation and showed that p21 is not expressed in the granule
cell layer (GCL) where mature neurons reside (Fig. 1A). Three
brain sections per animal derived from 3 mice were analyzed for
GFAP-, SOX2-, nestin- and p21 co-localization. p21 expression
was not detected in GFAP
+/SOX2
+ or in GFAP
+/nestin
+ cells
(data not shown), indicating that p21 is not expressed in radial
neuronal stem cells. In the SGZ, p21 is co-localized with SOX2
and with nestin in amplifying neuronal progenitors (Fig. 1B,C).
Whereas 2663.7% of SOX2
+ cells also were positive for p21,
more than 50% (56610.4%) of nestin
+ cells expressed p21. p21 is
expressed in DCX
+ neuroblasts (Fig. 1D), but not in differentiated
GFAP
+ astroglia (Fig. 1E). Thus, p21 is expressed in transient
amplifying neuronal progenitors and early developing neurons.
p21 is expressed in hippocampal-derived NPC in vitro
Hippocampal-derived NPC were isolated using the neurosphere
assay. Sphere-forming floating neural progenitors were cultured in
serum-free neurobasal A-medium under proliferating conditions
(see Methods) for 7 days, then the spheres were collected and
dispersed to individual cells, plated on polyornithine-covered
culture dishes and after 3 passages they were analyzed. We did not
find p21 expression in GFAP
+/SOX2
+ or in GFAP
+/nestin
+ cells,
therefore double-staining for p21- and nestin or SOX2 was carried
out. In three separate experiments, more than 3000 cells were
analyzed. The results show that 3964.9% of SOX2
+ cells and
29.463.7% of nestin
+ cells (Fig. 2A) also express p21. Therefore, in
vitro, p21 is expressed by transient amplifying neuronal progenitors
prior to neuronal differentiation. Next, it was determined whether
p21 is expressed in early stage developing neurons. NPC were
allowed to differentiate for only 3 days, at which time a proportion
of the cells start to express the markers of neuroblasts and became
DCX
+. In three separate experiments, 1600 DCX
+ cells were
analyzed, and 28.161.7% expressed p21 (Fig. 2A), showing that
p21 is expressed in neuroblasts. Unfortunately, there is no good
marker for early stage cells committed to glial lineage, so it is
difficult to assess whether p21 is also expressed in early glial
progenitors. After NPC were allowed to differentiate for 8 days
they lose nestin and SOX2, and generate primarily young neurons
and astroglia [26,27,28]. Cells were double-stained for p21 and
GFAP, a marker for differentiated astroglia in these conditions,
and for p21 and bIII-tubulin, a marker of immature post-mitotic
neurons that is recognized by antibodies to Tuj-1. The number of
cells co-expressing GFAP and p21, and Tuj-1 and p21 were
counted in three separate experiments and a total 3000 cells were
counted for each antibody. p21 was expressed in 1861.9% of Tuj-
1
+ cells (Fig. 2A) . Confirming the in vivo observations, p21 was not
detected in cells that differentiated into GFAP
+ cells (astroglia)
(Fig. 2A). Thus, p21 is expressed in progenitors committed to a
neuronal lineage, and its expression is negatively correlated with
the degree of differentiation (Fig. 2B).
p21 deletion increases NPC proliferation
Sphere formation, proliferation and differentiation of NPC
derived from the hippocampi of WT and p21-/- mice were
compared. NPC were isolated and cultured in growth medium.
Seven days after plating, the size of the spheres derived from the
hippocampi of p21-/- mice was markedly larger than those
derived from WT mice (Fig. 3A). All floating spheres were then
collected, dispersed and the number of cells was counted. The total
number of cells in the spheres derived from p21-/-mice was
significantly (4-fold) higher than that from WT mice (Fig. 3B).
Sphere self-renewal analysis was performed to analyze the
potential to form spheres. The percentage of cells able to form
new spheres was higher in the cell culture derived from p21-/-
mice compared to those derived from WT mice (1561v s1 0 62.3
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measure of proliferation potential, NPC were grown on coated slides
for 1 day and then fixed and stained for Ki67 and nestin, or SOX2.
The number of nestin
+ and SOX2
+ cells co-expressing Ki67 was
higher in NPC derived from p21-/- mice compared to WT mice
(Fig. 3D and 3E). Thus, NPC derived from hipocampi of p21-/-
mice have increased proliferation and self-renewal potentials. To test
whether cells expressing p21 proliferate, WT and p21-/- NPC were
fixed and double stained for p21 and Ki67. In WT cell culture, cells
positive for p21 were negative for Ki67, indicating that cells that
express p21 do not proliferate (Fig. 3F). Double–labeling confocal
analysis of WT NPC using a color-coded fluorogram confirmed that
these two proteins rarely co-express (Fig. 3G). These results indicate
thatwhenp21isabsent,proliferationisincreased,whereaswhenp21
is present, proliferation is restrained.
Transient suppression of p21 increases NPC proliferation
To account for the possibility of compensatory alterations in
p21-/- mice during development, conditional loss of function
studies were carried out using lentivirus expressing shRNA against
murine p21. Proliferating NPC cultures were infected with
lentivirus expressing shRNA or lentivirus expressing non-targeting
shRNA (control). The cells were collected, fixed and double-
stained for p21 and Ki67. Although the same number of cells was
initially plated (1,000 cells), at the time of collection there were
significantly more cells in NPC cultures treated with p21 shRNA
than in the control cultures (6,4006508 vs 5,0006202 per cover
slip, respectively; p,0.05, Fig. 4A). In NPC treated with shRNA
targeted against p21, the percentage of Ki67
+ proliferating
neuronal precursors was increased significantly (from 26.4
65.8% t0 40.265.1%, respectively, p,0.05), and at the same
time the percentage of p21
+ cells was decreased (40.8365.3% to
22.6761.9%, respectively, p,0.05 for both) (Fig. 4B and C),
confirming that when p21 is suppressed the proliferation of
neuronal progenitors is increased.
p21 is down-regulated and neurogenesis is increased by
chronic antidepressant treatment in WT mice
Previously we showed that chronic treatment with the
nonselective tricyclic antidepressant imipramine markedly de-
Figure 1. p21 is expressed in neuronal progenitors in the SGZ of the hippocampus. A) The confocal image shows that p21 (red) is
expressed in the SGZ of the dentate gyrus and is not expressed in mature neurons (NeuN, green) in the GCL. Here, and in other confocal images,
nuclei are stained with the DNA specific dye DAPI (blue). p21-positive cells appear pink. p21 is expressed mostly in nuclei; however, some cytoplasmic
staining also is observed. SGZ, subgranular zone; GCL, granular cell layer; ML, molecular layer; B–E) Confocal images depicting p21 co-localization
with neuronal markers in the SGZ of the hippocampus. p21-positive nuclei line the SGZ and appear light blue. Upper panel-low magnification (x20),
lower panel–higher magnification (x63). B) p21 (green) is co-localized with SOX2 (intranuclear, red). Cells that express both proteins appear yellow;
cells that expressed SOX2 only appear pink; C) p21 (green) is co-localized with nestin (cytoplasmic, red); D) p21 (green) is co-localized with DCX
(cytoplasmic, red); E) p21 (green) is not co-localized with GFAP (cytoplasmic, pink). Some of p21 positive cells are marked with arrows.
doi:10.1371/journal.pone.0027290.g001
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to determine whether other classes of reuptake inhibitor-type
antidepressants have similar effects on hippocampal p21 expres-
sion, WT mice were injected daily for 3 weeks with saline or one of
the following antidepressant drugs: the nonselective antidepressant
imipramine (10 mg/kg/i.p.); the selective norepinephrine reup-
take inhibitor desipramine (20 mg/kg/i.p.); or the serotonin-
selective reuptake inhibitor fluoxetine (10 mg/kg/i.p.). Twenty-
four hr after the last injection the mice were sacrificed and
hippocampal levels of p21 were analyzed by Western blot. All
three antidepressants produced a marked decline in p21 protein
levels in the hippocampus. We tested whether this effect is specific
for p21. No differences were observed in the levels of the Cdk
inhibitors p27 (Cip/Kip family) or p18 and p19 (Ink4/Arf family,
data not shown for p19) (Fig. 5A,B).
BrdU, which incorporates into nuclear DNA of proliferating
progenitors during the S phase of the cell cycle, was used to label
proliferating cells. To confirm that the antidepressant-induced
decreases in p21 were associated with increased neurogenesis,
separate groups of mice were treated as described above. Twenty
four hr after the last injection of drug (or saline), the mice were
injected with BrdU and then sacrificed 24 hr later. The number of
BrdU
+ cells in the SGZ was significantly higher in antidepressant-
treated compared to the saline-treated mice, showing that
antidepressant treatment increased cellular proliferation (Fig. 5C).
To determine the number of proliferating cells that expressed a
neuronal phenotype, slides were double-labeled with both BrdU
and DCX antibodies, and the number of BrdU
+/DCX
+ co-
labeled cells (proliferating neuronal progenitors) were determined.
The number of BrdU
+/DCX
+ cells was increased in all three
antidepressant-treated groups compared to saline-treated controls
(Fig. 5D). Therefore, chronic treatment with different classes of
reuptake inhibitor-type antidepressants decreased hippocampal
p21 expression and increased neurogenesis.
p21-/- mice exhibit higher levels of neurogenesis in
response to saline and lower levels in response to
imipramine
WT and p21-/- male mice were treated chronically with saline
or imipramine as described above. Twenty four hr after the end of
antidepressant treatment the mice were injected with BrdU as
described above and BrdU
+ cells were counted in the SGZ.
Compared to WT mice that received saline, the number of BrdU
+
and BrdU
+/DCX
+ co-labeled cells was significantly higher in the
saline-treated p21-/- mice, indicating increased neurogenesis.
Treatment with imipramine increased number of BrdU
+ and
BrdU
+/DCX
+ co-labeled cells in WT mice, but did not increase
the number BrdU
+ cells in p21-/- mice. There is a tendency for
imipramine to decrease BrdU labeling in p21-/- mice, although
this effect did not reach statistical significance. However,
impramine significantly reduced the number of BrdU
+/DCX
+
cells in p21-/- mice (Fig. 6A and B). Thus, neurogenesis decreased
rather than increased in p21-/- mice in response to treatment with
imipramine. Western blot analyses of hippocampi from WT and
p21-/- mice confirmed these observations (Fig. 6C). In WT mice,
imipramine treatment increased protein levels of both DCX and
NeuN (a marker of mature neurons), indicating increased
neurogenesis. In the saline-treated controls, levels of both DCX
Figure 2. p21 is expressed in hippocampal NPC of a neuronal lineage. Cultured neuronal progenitors were stained for p21 (intranucelar, red)
and various neuronal markers. A) co-localization of p21 and SOX2 (green, intranuclear, double-positive nuclei appear yellow; B) co-localization of p21
and nestin (green, cytoplasmic); In differentiating NPC, p21 co-localizes with C) DCX (green, cytoplasmic); and with D) Tuj-1 (green, cytoplasmic), but
not with E) GFAP (green, cytoplasmic). Numbers indicate the percentage of p21-positive cells among the total number of cells expressing a
respective marker. Counting was performed in triplicate (.500 cells per sample). Data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0027290.g002
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WT mice, again showing increased neurogenesis in p21-/- mice.
Although treatment with imipramine increased the level of these
proteins in WT mice, the expression levels of both DCX and
NeuN were markedly decreased after treatment with imipramine
in p21-/- mice. No differences in the levels of two other major Cdk
inhibitors p18 and p27 were found among treatment groups,
indicating that the effects of the antidepressants in either WT or
p21-/- mice do not involve these other Cdk inhibitors (Fig. 6C,D).
Caspase 3 is a member of the caspase family, and in apoptotic
cell caspase is cleaved to shorter isoforms to trigger the apoptotic
process [29]. After three weeks of imipramine treatment there
were no differences in the levels of cleaved caspase 3 protein
among treatment groups. However, after one week of imipramine
treatment the levels of cleaved caspase 3 were higher in the p21-/-
mice, indicating increased apoptosis (Fig. 6E,F). Apoptotic death
of rapidly proliferating neuronal progenitors at an early stage (i.e.,
in 1 week) might explain the decrease in the number of BrdU
+ and
BrdU
+/DCX
+ cells and in DCX and NeuN protein levels
observed later (i.e., in 3 weeks) in imipramine-treated p21-/- mice.
p21-/- mice do not show decreased immobility in the FST
in response to imipramine
For the FST, WT and p21-/- mice were treated chronically
with saline or imipramine as described above. Twenty four hr after
the end of antidepressant (or saline) treatment the mice underwent
the FST. Compared to WT mice that received saline, there was
less immobility in the saline-treated p21-/- mice (Fig. 6G).
Although imipramine treatment decreased immobility in the
WT mice, immobility was increased in the p21-/- mice. Thus,
imipramine does not show antidepressant activity in the FST in
p21-/- mice.
Figure 3. Increased proliferation of NPC derived from p21-/- mice. A) The spheres derived from WT and p21-/- hippocampi 7 days after
plating. Note bigger size and more cellularity in p21-/- spheres; B) Seven days after seeding, the NPC spheres were collected, dispersed and the
number of cells was counted; C) Sphere self-renewal analysis. NPC spheres were dispersed and cells were seeded at 0.5 cell/well into 96-well plates.
The percent of cells forming new spheres was determined after 10 days; D) The percent of Ki67-positive cells co-expressing nestin or SOX2. Counting
was performed in triplicate (.500 cells per sample). Data are presented as a mean 6 SEM, *, p,0.05, **, p,0.01; E) Representative confocal images of
proliferating NPC derived from WT and p21-/- hippocampi and stained for Ki67 (intranucelar, red) and nestin (cytoplasmic, green) or SOX2
(intranuclear, green). p21-/- NPC exhibit more Ki67-positive cells; F) Proliferating neuronal precursors derived from WT and p21-/- hippocampi and
stained for Ki67 (intranucelar, red) and p21 (intranuclear, green). Note that WT NPC cells positive for Ki67 are negative for p21; G) Double-labeling
analysis of WT NPC with a color-coded fluorogram. The confocal image shows the absence of co-localization between p21 (green) and Ki67 (red).
doi:10.1371/journal.pone.0027290.g003
Antidepressants Inhibit p21 in Hippocampus
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27290Discussion
The data indicate that p21 is involved in the fundamental
molecular mechanisms underlying the control of neurogenesis in
the hippocampus. The present study confirmed previous findings
that p21 is expressed exclusively in the SGZ of hippocampus, but
not in granular cell layer where the mature neurons reside [15]. In
the present study we found that p21 is expressed in transient
amplifying progenitors, neuroblasts and young developing neu-
rons. In NPC derived from the hippocampi of WT mice, p21 is co-
localized with both SOX2 and nestin in early stage neuronal
progenitors. After differentiation, GFAP
+ astrocytes do not express
p21, whereas p21 expression is evident in early stage both DCX
+
and immature bIII-tubulin
+ (Tuj-1
+) neurons. Co-labeling for p21
and Ki67 show that these two proteins rarely co-localize.
Therefore, when p21 is present, proliferation is restrained in
these cells.
The in vitro studies support this hypothesis. Compared to
neuropheres derived from WT mice, spheres derived from p21-/-
mice were larger in size, the spheres were comprised of more cells
and they exhibited higher spherogenic ability and increased
proliferation. In addition, the percentage of both SOX2
+ and
nestin
+ cells expressing Ki67 (proliferating cells) was higher in
NPC derived from p21-/- mice. The experiments using condi-
tional knock down of p21 in NPC from WT mice showed that
when p21 expression is decreased, proliferation of NPC is
increased. Taken together, these results strongly support the
hypothesis that p21 plays a fundamental role in regulating
neuronal lineage cell proliferation in the hippocampus and in
keeping these cells in a quiescent state. In vivo, saline-treated p21-/-
mice showed greater cellular proliferation in the SGZ (as detected
by increased BrdU labeling) and increased neurogenesis (as
indicated by more BrdU
+/DCX
+ co-labeled cells) compared to
WT mice. These results are in agreement with the finding of
increased proliferation in the lateral ventricle wall and in the
forebrain stem cells in young p21-/- mice [30].
Other published studies [2,6,7] have shown that chronic
treatment with nonselective, serotonin- and norepinephrine-
selective reuptake inhibitor-type antidepressants stimulate hippo-
campal neurogenesis. In the present study this was found to be
associated with decreased hippocampal p21 protein expression.
No significant changes were observed in the expression of other
Cdk inhibitors, showing that p21 plays an unique role in
antidepressant-induced increases in neurogenesis. These results
also indicate that a shared property of reuptake inhibitor-type
antidepressant drugs is that they decrease the expression of p21 in
the SGZ of the hippocampus. Although DMI appeared to have
the greatest suppressive effect on p21 expression, there were no
differences among the three antidepressants in terms of the
proliferating neuronal progenitors (i.e., stimulation of neurogen-
esis). It is important to point out that it is not appropriate to try to
draw conclusions regarding comparative potencies of the three
drugs used because equimolar doses were not administered, nor
were dose-response studies conducted.
Tissue specific factors can start or stop the proliferation of
mitotic cells. Out of three tasted major Cdk inhibitors (p21, p18
Figure 4. Conditional suppression of p21 enhances proliferation of WT NPC. A) One thousand WT NPC cells were kept in proliferating
conditions for 4 days. Cells were cultured in 24-well plates in triplicates. The mean number of cells at the time of collection; B) Cells were fixed and
stained for Ki67 or p21 . The graph depicts the percentage of p21- or Ki67-positive cells in each culture. Counting was performed in triplicates (.500
cells per sample). Data are presented as a mean 6 SEM, *, p,0.05. Two independent experiments were conducted, and representative results are
shown; C) Representative confocal images of NPC treated with either control lentivirus (control) or lentivirus expressing p21 shRNA. The cells were
stained for Ki67 (intranucelar, red) and p21 (intranuclear, green). Note the increased number of Ki67-positive and the decreased number of p21-
positive cells after p21 shRNa treatment.
doi:10.1371/journal.pone.0027290.g004
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antidepressant treatment. We can speculate that in the hippo-
campus, some tissue-specific factors selectively affect p21. Similar
tissue specificity has been demonstrated for other brain regions.
For example, TGFb exerts its anti-proliferative properties in the
cerebellum, but not in the hippocampus [31]. On the other hand,
Smad7, one of the transcription factors of the TGFb signaling
pathway, induces proliferation of SGZ and SVZ neuronal
progenitors, independent of TGFb signaling [32]. We also
examined other Cdk inhibitors using immunofluorescent analysis
(not shown here) and found that p27 is most abundantly
expressed in all parts of the dentate gyrus. Therefore, it is likely
that p27 maintains quiescence of neuronal stem cells and
differentiated neurons in the granular cell layer.
An important finding is that neurogenesis was not increased in
p21-/- mice chronically treated with imipramine, suggesting that
p21 suppression is not simply a correlate of increased neuronal cell
proliferation, but that down-regulation of p21 is required for the
stimulation of neurogenesis produced by this class of antidepres-
sants. In fact, in p21-/- mice there was a decrease, rather than an
increase in the number of both BrdU
+ and DCX
+/BrdU
+ cells in
response to chronic imipramine treatment. These observations
were supported by the results showing that imipramine decreased
protein levels of both DCX and NeuN in the p21-/- mice. The
mechanism underlying the decrease is not clear. Cleaved caspase 3
is a protein implicated in cell death signaling pathways [33]. In
other cell types, chronic treatment with antidepressants can induce
apoptosis via caspase 3 activation [34,35]. In the hippocampus,
apoptosis occurs mostly in proliferating early neuronal progenitors
[36,37], however it might also occur, although at a slower rate, at
the post-mitotic stage [37,38]. In WT mice, chronic imipramine
treatment did not induce changes in apoptosis as evident by
cleaved caspase 3 levels. Besides its effects on cell cycle regulation,
p21 also has antiapoptotic properties [39]. It is possible that in the
absence of p21, NPC become vulnerable to antidepressant-
induced apoptosis. Another possibility is that p21 might directly
interact and inactivate caspase 3 and its downstream apoptotic
pathway [40], and in the absence of p21, caspase 3 is activated and
apoptosis is induced. This is supported by the finding that in
p21-/- mice, cleaved caspase 3 protein levels were increased after
one week of imipramine treatment, indicating induced apoptosis.
This could explain the decreased levels of neurogenesis in p21-/-
mice after three weeks of treatment with imipramine. The fact that
no changes in the levels of cleaved caspase 3 were found after three
weeks might indicate that by this time very few early neuronal
progenitors proliferate in the SGZ of p21-/- mice.
Although there is evidence pointing to a mechanistic link
between neurogenesis and the mechanism of action of antidepres-
sant drugs, the role of neurogenesis in the pathophysiology of
depression remains unclear. Suppression of neurogenesis by
hippocampus-directed irradiation [10] or by using transgenic
animals [41] does not produce a depressive or anxious phenotype
per se, but does reduce some of the behavioral effects of
antidepressants [10]. Recent findings also indicate that adult-born
hippocampal neurons are required for normal stress response, and
support a direct role of neurogenesis in stress-related depressive
behavior [42]. The link between depression in human and
increased immobility in the forced swim test in the mouse must
be drawn with great caution [43], but in the present study there
was a clear-cut inverse relationship between immobility in the FST
Figure 5. Chronic treatment with antidepressants suppressed p21 expression and increased neuronal proliferation in the SGZ of
hippocampus. A) Western blot analysis of p21 and other Cdk inhibitors in hippocampus of mice chronically treated with normal saline (NS),
imipramine (IP), desipramine (DMI) or fluoxetine (FL). For each sample hippocampi from 5 mice/group were pooled; B) Quantitative analysis of three
independent experiments. The intensity of p21 bands was measured, normalized to the loading control (b actin) and the ratios were corrected to NS
control to quantify relative changes; C) Number of BrdU
+ cells. Non-parametric Kruskal-Wallis test [(H3,N=20)=11.75, p,0.008]. D) Number of BrdU
+/
DCX
+ cells. One way ANOVA followed by Dunnett’s post-hoc test [(F3,16)=3.88, p=0.029 for all groups] in the SGZ. For each sample hippocampi
from 5 mice/group were analyzed. Data are presented as a mean 6 SEM.
doi:10.1371/journal.pone.0027290.g005
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mice showed less immobility in the FST and increased
neurogenesis compared to saline-treated WT mice. However,
treatment with imipramine reduced immobility and increased
neurogenesis in the WT mice, but increased immobility and
decreased neurogenesis in the p21-/- mice. The last imipramine
injection was administered to the mice 24 hr before the FST,
which rules out acute drug/genotype interactions. These results
indicate that imipramine does not show antidepressant activity in
the FST or stimulate neurogenesis in p21-/- mice, and strongly
suggest that p21 is required for the stimulation of neurogenesis and
some of the behavioral effects produced by reuptake inhibitor-type
antidepressant drugs.
In summary, p21 regulates the proliferation of neuronal
progenitors in the hippocampus, and the stimulation of neuro-
genesis produced by reuptake inhibitor-type antidepressants might
be a consequence of decreased p21 expression and the subsequent
release of neuronal progenitor cells from the blockade of
proliferation. Because many antidepressants stimulate neurogen-
esis, it is possible that their shared common mechanism of action is
suppression of p21. At this point the mechanisms underlying this
effect are not known. As direct effects of the antidepressants on
p21 expression in NPC in vitro were not found (data not shown), it
is likely that antidepressants suppress p21 secondary to enhancing
neurotransmission. Similar effects was shown for the long term
lithium treatment which suppress p53 expression in cerebellum
granular cells [44], and p21 is a transcriptional target for p53[45].
Further studies will be needed to determine the mechanisms and
pathways underlying suppressive effects of antidepressants on p21
expression.
Figure 6. SGZ neurogenesis and immobility in the FST in p21-/- mice chronically treated with normal saline (NS) or imipramine (IP).
A) Number of BrdU
+ cells. The effects of treatment x genotype were assessed by two-way ANOVA followed by Neuman-Keuls post-hoc test
[(F1,16,)=20.18, p=0.004]; B) Number of BrdU
+/DCX
+ cells in the SGZ. Two-way ANOVA [(F1,16)=23.483, p=0.00018]. Data are presented as a mean
6 SEM, *, p,0.05 vs WT NS, #,p ,0.05 vs p21-/- NS; Western blot analysis of C) Neuronal markers and Cdk inhibitors; and D) Cleaved caspase 3. For
each sample hippocampi from 3 mice/group were pooled; E, F) Quantitative analysis of three independent experiments. The intensity of E) DCX and
NeuN, and F) cleaved caspase 3 bands were measured, normalized to the loading control (b actin) and ratios were corrected to WT NS control to
quantify relative changes. Data are presented as a mean 6 SEM, *, p,0.05 vs WT NS; G) Immobility in the FST. The values are the total time spent
immobile in sec. Data are presented as a mean 6 SEM, n=9–10/group *, p,0.05 vs WT NS or p21-/- NS, #,p ,0.05 vs p21-/- NS. Imipramine
decreased immobility in WT treated mice [(M=143.08 SD=39.02) compared to WT untreated (M=176.99 SD=20.39) mice, t(17)=2.33, P =0.032].
The effects of treatment and genotype were assessed by two-way ANOVA followed by Neuman-Keuls post-hoc test[ F(1, 33)=12.551, p=.001]. The
p21-/- NS group had significantly less immobility time compared to WT NS whereas the p21-/- IP treated group had significantly more immobility
than the p21-/- NS group. This indicates that antidepressant treatment produces a paradoxical effect in the p21-/- mice.
doi:10.1371/journal.pone.0027290.g006
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